Contribution: Industrial Research Assistance Program – Contributions to Firms
Somru BioScience Inc.
$304,637.00
Generation of Chicken Monoclonal Antibodies using Recombinant DNA Technology
FY 2017-18 · 2017-05-15
Summary
The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immune system. This platform will allow scientists to reach into unexplored regions of protein targets (i.e. novel epitopes) by exploiting the benefits of employing a species that is phylogenetically distant from humans, thereby providing access to previously unavailable epitopes. These antibodies can be utilized for research, diagnostics and therapeutics processes.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Charlottetown|Charlottetown, Prince Edward Island, Canada
Recipient Type
For-profit organization
Business Number
806733887
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 2 | 2017-05-15 | 2017-18 | $0.00 |
| 3 | 2017-05-15 | 2017-18 | $304,637.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 120 days. The total amended value is 66,885 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 120 jours. La valeur totale des modifications est de 66 885 dollars.
Agreement End Date
2019-04-30
Agreement Number
885833
Agreement Start Date
2017-05-15
Agreement Title
Generation of Chicken Monoclonal Antibodies using Recombinant DNA Technology
Agreement Title (French)
Génération d'anticorps monoclonaux de poulet en utilisant la technologie recombinante de l'ADN
Agreement Type
Contribution
Agreement Value
$304,637.00
Amendment Date
2019-01-02
Amendment Number
3
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
The Firm intends to develop and validate a novel recombinant antibody discovery platform using a chicken immune system. This platform will allow scientists to reach into unexplored regions of protein targets (i.e. novel epitopes) by exploiting the benefits of employing a species that is phylogenetically distant from humans, thereby providing access to previously unavailable epitopes. These antibodies can be utilized for research, diagnostics and therapeutics processes.
Description (French)
L'entreprise a l'intention de développer et valider une nouvelle plate-forme de découverte d'anticorps recombinants en utilisant un système immunitaire de poulet. Cette plate-forme permettra aux scientifiques d’atteindre des régions inexplorées de cibles protéiques (c’est-à-dire de nouveaux épitopes) en exploitant les avantages de l’emploi d’une espèce éloignée phylogénétiquement des humains, donnant ainsi accès à des épitopes auparavant indisponibles. Ces anticorps peuvent être utilisés pour la recherche, les diagnostics et les processus thérapeutiques.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Charlottetown
Federal Riding (French)
Charlottetown
Federal Riding Number
11002
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
806733887
Recipient City
Charlottetown|Charlottetown
Recipient Country
CA
Recipient Legal Name
Somru BioScience Inc.
Recipient Postal Code
C1E 0B7
Recipient Province or Territory
PE
Recipient Type
F
Reference Number
172-2018-2019-Q1-885833
